Zurich, 2 May 2023: Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the year 2022 on 31 May 2023 at the latest. As a company listed on SIX, Achiko is required to publish its annual report, together with the annual financial statements, within four months of the balance sheet date.
The Company continues to be challenged by both opportunities presented by outstanding results, and last mile manufacturing issues which have cascaded to affect operations, which includes financial operations. As a result, the publication of the annual report 2022, together with the annual financial statements and the audit report, will occur by 31 May 2023. Achiko filed an exemption request with SIX Exchange Regulation (SER) regarding the publication of the annual report and the annual financial statements 2022. On 28 April 2023, SER granted Achiko the requested extension.
As required by SER, Achiko hereby reprints para. I of SER’s respective decision:
“The exemption application of Achiko (Issuer) dated 28 April 2023 requesting an extension of the deadline to publish its 2022 annual report and to file such report with SIX Exchange Regulation AG until 31 May 2023 at the latest is granted with the following reservation (lit. b and c):
a. SIX Exchange Regulation AG reserves the right to suspend trading of the registered shares of the Issuer in case its 2022 annual report is not published in accordance with the provisions on ad hoc publicity (Art. 53 of the Listing Rules [LR] in connection with the Directive on Ad hoc Publicity [DAH]) and not filed with SIX Exchange Regulation AG until Wednesday, 31 May 2023, 11.59 pm CET, at the latest.
b. Achiko is required to publish a notice in accordance with the provisions on ad hoc publicity (Art. 53 LR in connection with the DAH) concerning this decision until Tuesday, 02 May 2023, 7.30 am CET, at the latest. The notice must contain:
– the unaltered reproduction of the wording of para. I. of this decision, placed in a prominent position;
-the reasons for the application of the Issuer requesting an extension of the deadline to publish its 2022 annual report and to file such report with SIX Exchange Regulation AG.
c. Achiko is required to publish a notice in accordance with the provisions on ad hoc publicity (Art. 53 LR in connection with the DAH) concerning this decision until Monday, 15 May 2023, 7.30 am CET, at the latest. The notice must contain:
-the unaudited key figures such as net revenues, EBITDA, EBIT, profit/loss, balance sheet total, equity etc. for the annual results 2022.”
ABOUT ACHIKO AG
Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that put people first. The Company’s lead product, AptameX™, is a rapid, reliable Covid-19 test with a companion app, Teman Sehat™, offering a user-friendly digital health passport. AptameX™ and Teman Sehat™ were launched in Indonesia in mid-2021 and AptameX™ received the CE Mark in the European Union in May 2022.
Headquartered in Zurich, Achiko has offices in Jakarta, and staff around the world.
Switzerland & Global
Farner Consulting Ltd
T: +41 44 266 67 67
This communication expressly or implicitly contains certain forward-looking statements concerning Achiko AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. In consequence, no undue reliance should be placed on these forward-looking statements by investors. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.